Skip to main content
  • Cardioform Septal Occluder Wins FDA Approval for PFO Closure Decision comes nearly a year after positive REDUCE trial

    The FDA cleared an expanded indication for Cardioform Septal Occluder that now puts the device on the market for patent foramen ovale (PFO) closure to reduce risk of recurrent ischemic stroke, device manufacturer Gore announced.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details